Globe Life Inc (GL) - Net Assets
Based on the latest financial reports, Globe Life Inc (GL) has net assets worth $6.08 Billion USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($30.97 Billion) and total liabilities ($24.88 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check GL intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $6.08 Billion |
| % of Total Assets | 19.65% |
| Annual Growth Rate | 1.29% |
| 5-Year Change | -30.87% |
| 10-Year Change | 30.82% |
| Growth Volatility | 22.79 |
Globe Life Inc - Net Assets Trend (1985–2025)
This chart illustrates how Globe Life Inc's net assets have evolved over time, based on quarterly financial data. See Globe Life Inc (GL) defensive interval to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Globe Life Inc (1985–2025)
The table below shows the annual net assets of Globe Life Inc from 1985 to 2025. For live valuation and market cap data, see GL market cap.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $5.97 Billion | +12.61% |
| 2024-12-31 | $5.31 Billion | +18.25% |
| 2023-12-31 | $4.49 Billion | +13.60% |
| 2022-12-31 | $3.95 Billion | -54.30% |
| 2021-12-31 | $8.64 Billion | -1.46% |
| 2020-12-31 | $8.77 Billion | +20.25% |
| 2019-12-31 | $7.29 Billion | +34.70% |
| 2018-12-31 | $5.42 Billion | -13.10% |
| 2017-12-31 | $6.23 Billion | +36.45% |
| 2016-12-31 | $4.57 Billion | +12.61% |
| 2015-12-31 | $4.06 Billion | -13.67% |
| 2014-12-31 | $4.70 Billion | +24.39% |
| 2013-12-31 | $3.78 Billion | -13.42% |
| 2012-12-31 | $4.36 Billion | +3.14% |
| 2011-12-31 | $4.23 Billion | +5.30% |
| 2010-12-31 | $4.02 Billion | +18.16% |
| 2009-12-31 | $3.40 Billion | +52.90% |
| 2008-12-31 | $2.22 Billion | -33.14% |
| 2007-12-31 | $3.32 Billion | -3.89% |
| 2006-12-31 | $3.46 Billion | +0.77% |
| 2005-12-31 | $3.43 Billion | +0.38% |
| 2004-12-31 | $3.42 Billion | +5.55% |
| 2003-12-31 | $3.24 Billion | +8.15% |
| 2002-12-31 | $3.00 Billion | +13.41% |
| 2001-12-31 | $2.64 Billion | +10.27% |
| 2000-12-31 | $2.40 Billion | +9.56% |
| 1999-12-31 | $2.19 Billion | -10.85% |
| 1998-12-31 | $2.45 Billion | +15.37% |
| 1997-12-31 | $2.13 Billion | +16.65% |
| 1996-12-31 | $1.82 Billion | +2.27% |
| 1995-12-31 | $1.78 Billion | +43.41% |
| 1994-12-31 | $1.24 Billion | -12.33% |
| 1993-12-31 | $1.42 Billion | +17.75% |
| 1992-12-31 | $1.20 Billion | +4.68% |
| 1991-12-31 | $1.15 Billion | +14.63% |
| 1990-12-31 | $1.00 Billion | +6.00% |
| 1989-12-31 | $946.30 Million | -75.92% |
| 1988-12-31 | $3.93 Billion | -0.28% |
| 1987-12-31 | $3.94 Billion | -0.78% |
| 1986-12-31 | $3.97 Billion | +11.07% |
| 1985-12-31 | $3.58 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Globe Life Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 925.2% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $8.55 Billion | 143.05% |
| Common Stock | $92.22 Million | 1.54% |
| Other Comprehensive Income | $-1.77 Billion | -29.65% |
| Total Equity | $5.97 Billion | 100.00% |
Globe Life Inc Competitors by Market Cap
The table below lists competitors of Globe Life Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Bosch Limited
NSE:BOSCHLTD
|
$12.82 Billion |
|
QXO, Inc.
NASDAQ:QXO
|
$12.83 Billion |
|
ZTO Express (Cayman) Inc
F:ZTOA
|
$12.83 Billion |
|
ZTO EXPRESS (CAYMAN)
F:ZTOB
|
$12.83 Billion |
|
China Galaxy Securities Co Ltd Class A
SHG:601881
|
$12.81 Billion |
|
ALTEOGEN Inc
KQ:196170
|
$12.81 Billion |
|
Sanan Optoelectronics Co Ltd
SHG:600703
|
$12.81 Billion |
|
Tele2 AB (publ)
ST:TEL2-B
|
$12.80 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Globe Life Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 5,305,520,000 to 5,974,579,000, a change of 669,059,000 (12.6%).
- Net income of 1,161,155,000 contributed positively to equity growth.
- Dividend payments of 86,067,000 reduced retained earnings.
- Share repurchases of 880,983,000 reduced equity.
- New share issuances of 164,448,000 increased equity.
- Other comprehensive income increased equity by 258,276,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $1.16 Billion | +19.43% |
| Dividends Paid | $86.07 Million | -1.44% |
| Share Repurchases | $880.98 Million | -14.75% |
| Share Issuances | $164.45 Million | +2.75% |
| Other Comprehensive Income | $258.28 Million | +4.32% |
| Other Changes | $52.23 Million | +0.87% |
| Total Change | $- | 12.61% |
Book Value vs Market Value Analysis
This analysis compares Globe Life Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.31x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 84.47x to 2.31x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1985-12-31 | $2.02 | $170.76 | x |
| 1986-12-31 | $1.87 | $170.76 | x |
| 1987-12-31 | $2.02 | $170.76 | x |
| 1988-12-31 | $2.06 | $170.76 | x |
| 1989-12-31 | $2.54 | $170.76 | x |
| 1990-12-31 | $2.70 | $170.76 | x |
| 1991-12-31 | $3.13 | $170.76 | x |
| 1992-12-31 | $3.39 | $170.76 | x |
| 1993-12-31 | $4.29 | $170.76 | x |
| 1994-12-31 | $3.86 | $170.76 | x |
| 1995-12-31 | $4.93 | $170.76 | x |
| 1996-12-31 | $5.06 | $170.76 | x |
| 1997-12-31 | $6.80 | $170.76 | x |
| 1998-12-31 | $7.40 | $170.76 | x |
| 1999-12-31 | $6.83 | $170.76 | x |
| 2000-12-31 | $7.63 | $170.76 | x |
| 2001-12-31 | $8.92 | $170.76 | x |
| 2002-12-31 | $10.51 | $170.76 | x |
| 2003-12-31 | $12.49 | $170.76 | x |
| 2004-12-31 | $13.59 | $170.76 | x |
| 2005-12-31 | $14.41 | $170.76 | x |
| 2006-12-31 | $15.21 | $170.76 | x |
| 2007-12-31 | $15.42 | $170.76 | x |
| 2008-12-31 | $11.16 | $170.76 | x |
| 2009-12-31 | $18.19 | $170.76 | x |
| 2010-12-31 | $21.75 | $170.76 | x |
| 2011-12-31 | $25.67 | $170.76 | x |
| 2012-12-31 | $29.70 | $170.76 | x |
| 2013-12-31 | $27.06 | $170.76 | x |
| 2014-12-31 | $35.42 | $170.76 | x |
| 2015-12-31 | $31.99 | $170.76 | x |
| 2016-12-31 | $37.32 | $170.76 | x |
| 2017-12-31 | $52.37 | $170.76 | x |
| 2018-12-31 | $46.99 | $170.76 | x |
| 2019-12-31 | $65.49 | $170.76 | x |
| 2020-12-31 | $81.80 | $170.76 | x |
| 2021-12-31 | $83.77 | $170.76 | x |
| 2022-12-31 | $39.90 | $170.76 | x |
| 2023-12-31 | $46.56 | $170.76 | x |
| 2024-12-31 | $62.60 | $170.76 | x |
| 2025-12-31 | $73.90 | $170.76 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Globe Life Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 19.43%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 19.36%
- • Asset Turnover: 0.19x
- • Equity Multiplier: 5.16x
- Recent ROE (19.43%) is above the historical average (16.31%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1985 | 17.09% | 12.07% | 0.37x | 3.87x | $68.52 Million |
| 1986 | 22.41% | 13.18% | 0.38x | 4.51x | $113.54 Million |
| 1987 | 21.73% | 12.61% | 0.38x | 4.60x | $108.25 Million |
| 1988 | 22.29% | 10.82% | 0.38x | 5.48x | $99.31 Million |
| 1989 | 23.62% | 12.93% | 0.33x | 5.50x | $121.85 Million |
| 1990 | 24.28% | 12.76% | 0.32x | 5.87x | $134.82 Million |
| 1991 | 22.84% | 12.75% | 0.31x | 5.71x | $138.57 Million |
| 1992 | 23.80% | 12.97% | 0.30x | 6.07x | $153.93 Million |
| 1993 | 21.02% | 13.67% | 0.28x | 5.39x | $156.17 Million |
| 1994 | 21.64% | 13.93% | 0.23x | 6.76x | $144.64 Million |
| 1995 | 9.01% | 6.93% | 0.22x | 5.89x | $-15.66 Million |
| 1996 | 19.11% | 14.12% | 0.23x | 6.02x | $148.44 Million |
| 1997 | 15.89% | 14.80% | 0.21x | 5.16x | $125.15 Million |
| 1998 | 10.82% | 11.33% | 0.19x | 4.98x | $18.49 Million |
| 1999 | 13.74% | 12.30% | 0.18x | 6.09x | $74.62 Million |
| 2000 | 16.44% | 14.37% | 0.19x | 5.89x | $141.76 Million |
| 2001 | 14.28% | 13.17% | 0.22x | 4.98x | $106.80 Million |
| 2002 | 13.58% | 14.03% | 0.22x | 4.33x | $102.14 Million |
| 2003 | 13.27% | 14.67% | 0.22x | 4.15x | $106.09 Million |
| 2004 | 13.70% | 15.25% | 0.22x | 4.17x | $126.58 Million |
| 2005 | 14.43% | 15.85% | 0.21x | 4.30x | $152.11 Million |
| 2006 | 14.99% | 15.16% | 0.23x | 4.33x | $172.71 Million |
| 2007 | 15.87% | 15.13% | 0.23x | 4.58x | $195.07 Million |
| 2008 | 20.35% | 13.59% | 0.25x | 6.09x | $229.97 Million |
| 2009 | 11.91% | 12.57% | 0.20x | 4.71x | $65.06 Million |
| 2010 | 12.42% | 14.81% | 0.21x | 4.02x | $97.24 Million |
| 2011 | 11.76% | 14.72% | 0.20x | 4.06x | $74.27 Million |
| 2012 | 12.14% | 14.75% | 0.19x | 4.30x | $93.15 Million |
| 2013 | 13.99% | 15.12% | 0.19x | 4.82x | $150.84 Million |
| 2014 | 11.56% | 13.69% | 0.20x | 4.30x | $73.19 Million |
| 2015 | 13.00% | 14.00% | 0.19x | 4.90x | $121.54 Million |
| 2016 | 12.04% | 13.97% | 0.18x | 4.69x | $93.09 Million |
| 2017 | 23.33% | 34.99% | 0.18x | 3.77x | $830.86 Million |
| 2018 | 12.95% | 16.29% | 0.19x | 4.26x | $159.48 Million |
| 2019 | 10.43% | 16.80% | 0.17x | 3.56x | $31.36 Million |
| 2020 | 8.34% | 15.45% | 0.16x | 3.31x | $-145.34 Million |
| 2021 | 8.62% | 14.57% | 0.17x | 3.44x | $-119.32 Million |
| 2022 | 18.73% | 14.18% | 0.20x | 6.58x | $344.75 Million |
| 2023 | 21.64% | 17.82% | 0.19x | 6.25x | $522.07 Million |
| 2024 | 20.18% | 18.53% | 0.20x | 5.48x | $540.21 Million |
| 2025 | 19.43% | 19.36% | 0.19x | 5.16x | $563.70 Million |
Industry Comparison
This section compares Globe Life Inc's net assets metrics with peer companies in the Insurance - Life industry.
Industry Context
- Industry: Insurance - Life
- Average net assets among peers: $2,587,280,031
- Average return on equity (ROE) among peers: 23.83%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Globe Life Inc (GL) | $6.08 Billion | 17.09% | 4.09x | $12.82 Billion |
| Atlantic American Corporation (AAME) | $31.80 Million | 29.56% | 5.46x | $38.14 Million |
| Abacus Life Inc. (ABL) | $28.15 Million | -0.19% | 1.10x | $827.97 Million |
| Abacus Global Management, Inc. (ABX) | $164.07 Million | 5.80% | 1.02x | $85.84K |
| Abacus Global Management, Inc. (ABX) | $1.30 Million | 50.90% | 0.12x | $857.55 Million |
| Aflac Incorporated (AFL) | $642.40 Million | 16.95% | 8.45x | $58.77 Billion |
| Brighthouse Financial Inc (BHF) | $16.84 Billion | 6.65% | 12.46x | $3.62 Billion |
| Citizens Inc (CIA) | $1.20 Million | 8.33% | 3.92x | $278.04 Million |
| CNO Financial Group Inc (CNO) | $2.82 Billion | 81.56% | 9.62x | $4.55 Billion |
| F&G Annuities & Life Inc. (FG) | $2.76 Billion | 14.93% | 12.30x | $3.64 Billion |
About Globe Life Inc
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products to lower middle- and middle-income families in the United States. It operates in three segments: Life Insurance, Supplemental Health Insurance, and Investments. The company offers whole, term, and other life insurance products, as well as life insurance for children; Medicare supplement and… Read more